---
title: "Outlook Therapeutics sells 8.54M shares in registered direct offering to GMS Ventures"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/288114626.md"
description: "Outlook Therapeutics completed a registered direct offering, selling approximately 8.54 million common shares to GMS Ventures and Investments. The transaction was executed under a securities purchase agreement dated May 28, 2026, utilizing the company's effective Form S-3 registration statement. This event is classified as corporate finance related information."
datetime: "2026-05-29T20:33:01.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/288114626.md)
  - [en](https://longbridge.com/en/news/288114626.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/288114626.md)
---

# Outlook Therapeutics sells 8.54M shares in registered direct offering to GMS Ventures

**Outlook Therapeutics completed a registered direct offering of 8,539,709 common shares to GMS Ventures and Investments.**

**Key Highlights:**

-   Company sold 8,539,709 shares of common stock to GMS Ventures and Investments under a securities purchase agreement dated May 28, 2026.
-   Offering was executed as a registered direct offering using the company’s effective Form S-3 registration statement (File No. 333-278340).
-   The Form S-3 originally filed March 28, 2024 became effective April 5, 2024, and the sale was made pursuant to its base prospectus and prospectus supplement.

Original SEC Filing: Outlook Therapeutics, Inc. \[ OTLK \] - 8-K - May. 29, 2026

**Disclaimer**

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.

### Related Stocks

- [OTLK.US](https://longbridge.com/en/quote/OTLK.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [VHT.US](https://longbridge.com/en/quote/VHT.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [IXJ.US](https://longbridge.com/en/quote/IXJ.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md)
- [IHE.US](https://longbridge.com/en/quote/IHE.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [BIS.US](https://longbridge.com/en/quote/BIS.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [XLV.US](https://longbridge.com/en/quote/XLV.US.md)
- [LABD.US](https://longbridge.com/en/quote/LABD.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)

## Related News & Research

- [Outlook Therapeutics Prices $5 Million Registered Direct Offering](https://longbridge.com/en/news/288026013.md)
- [Outlook Therapeutics announces $5M registered direct offering priced at-the-market](https://longbridge.com/en/news/283671806.md)
- [BUZZ-Outlook Therapeutics jumps on plans to resubmit marketing application for eye disease treatment](https://longbridge.com/en/news/287634369.md)
- [Outlook Therapeutics Wins FDA Appeal For NAMD Therapy; Stock Up](https://longbridge.com/en/news/287640138.md)
- [Outlook Therapeutics Q2 adjusted EPS misses analyst expectations](https://longbridge.com/en/news/286608989.md)